-
Roche to Acquire Telavant Holdings in $7.1 Billion Deal
Swiss healthcare company Roche has announced its plans to acquire Telavant Holdings in a $7.1 billion transaction.
2023-10-23 14:52 -
Newly Approved Drugs: Dautocallixtinib, Methylsulfonic Acid Ritlecitinib, Tongluo Mingmu Capsules, P...
Newly Approved Drugs: Dautocallixtinib, Methylsulfonic Acid Ritlecitinib, Tongluo Mingmu Capsules, Pediatric Purple Pearl Lung Syrup, Fructus Aurantii...
2023-10-23 14:48 -
Positive Results from innovaTV301 Study: TIVDAK Shows Promise in Advanced Cervical Cancer Treatment
On October 22nd, Seagen and Genmab, partners in the pharmaceutical industry, jointly announced the results of the global Phase 3 clinical trial, innov...
2023-10-23 13:53 -
Approval Granted for Huadong Medicine's Liraglutide Injection as the First Domestic GLP-1 Weight-Los...
According to the latest search results, the market approval application for Liraglutide Injection by Huadong Medicine for the indication of obesity or...
2023-10-16 18:00 -
BioMap and Sanofi Forge Groundbreaking Strategic Partnership in AI-driven Drug Development
BioMap, a leading company in the field of life sciences, has announced a breakthrough strategic partnership with Sanofi aimed at jointly developing ar...
2023-10-16 17:39 -
Sihuan Pharmaceutical Recognized as a Leading Innovator in China's Pharmaceutical Industry
Sihuan Pharmaceutical Holdings Group Ltd., a leading pharmaceutical company, is delighted to announce its selection as one of the first echelon of ent...
2023-10-16 17:19 -
Tempest Therapeutics' Breakthrough in Liver Cancer Treatment Sends Stock Soaring
On October 11th, Tempest Therapeutics made a groundbreaking announcement regarding their Phase Ib/II study on TPST-1120, a PPAR⍺ antagonist, for pati...
2023-10-16 16:51 -
India's Quest for Pharma Self-Sufficiency: Reducing Dependence on China
India, known as the "pharmacy of the world," had embarked on an ambitious plan in 2022 to reduce its dependence on China for key raw materials in the ...
2023-09-26 17:01 -
Leqembi Receives Approval in Japan for the Treatment of Alzheimer's Disease: A Milestone in Slowing ...
On September 25th, Weichai and Bojian jointly announced that Leqembi injection (200mg, 500mg, lecanemab) has been approved in Japan for the treatment ...
2023-09-26 16:56 -
Hansoh Pharma's Zolbetuximab Receives BLA Acceptance for Gastric Cancer Treatment in China
On August 1st, Hansoh Pharma announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) has accepted t...
2023-08-01 16:20
Hot News
- SABIC Shuts Down 865,000-Ton U... Jul 02, 2025
- European Petrochemical Industr... Jun 26, 2025
- Malaysia Proposes Major Food R... Jun 26, 2025
- The Truth Behind the US-China ... Jun 30, 2025
- Sally Beauty Acquires Flair Ha... Jul 07, 2025
Related Products
Related Producers
